Prichek-GMP 1 Tablet ER
Marketer
Indoco Remedies Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Prichek-GMP 1 Tablet ER
GlycemaControl ER 1mg is a dual-action formulation designed to manage blood glucose. This medication, used in conjunction with diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin utilization, consequently reducing blood sugar. GlycemaControl ER 1mg should be administered precisely as prescribed by your physician. Ingestion with food is recommended to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume the usual schedule. Never double the dose. An overdose can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Other potential side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and upper respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Kidney function tests will be assessed by your doctor before initiating treatment. Limit alcohol consumption during treatment, as this may heighten the risk of adverse reactions.
Uses of Prichek-GMP 1 Tablet ER
Managing type 2 diabetes
Major Benefits of Prichek-GMP 1 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Prichek-GMP 1 Extended-Release tablet should be taken with a meal.
Common Side effects of Prichek-GMP 1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Prichek-GMP 1 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or dividing it. It's recommended to take Prichek-GMP 1 Tablet ER with a meal.
How Prichek-GMP 1 Tablet ER works:
Prichek-GMP 1 Extended-Release tablet combines glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Prichek-GMP 1 Tablet ER is dangerous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Prichek-GMP tablets may pose pregnancy risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the benefits against potential risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Prichek-GMP tablets (1 mg) likely pose a risk during lactation. Available human data indicates potential drug transfer to breast milk, possibly harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Prichek-GMP 1 Tablet ER cautiously, potentially requiring dosage modification. Consult your physician. Prichek-GMP 1 Tablet ER is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Exercise caution when administering Prichek-GMP 1 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Prichek-GMP 1 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Prichek-GMP 1 Tablet ER :
Should you forget a Prichek-GMP 1 Tablet ER dose, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Prichek-GMP 1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



